Editorial ArticleHigh-sensitivity cardiac troponin I testing: A compelling point of care option for the emergency department
Industry NewsGammaDelta Therapeutics initiates first-in-human Phase 1 trial of GDX012 for the treatment of acute myeloid leukemia